Skip to main content

Table 1 Patient characteristics

From: Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation

Case no.

Age (y)

Gender

Prescribed dose (Gy(RBE))

Chemotherapy

Risk-group

CSI

Boost

1

7

F

23.4

30.6

CD

SR

2

4

F

23.4

30.6

CD

SR

3

5

M

23.4

30.6

HD

SR

4

10

M

23.4

30.6

CD

SR

5

4

M

23.4

30.6

HD

SR

6

4

M

27.0

27.0

HD

HR

7

6

M

30.6

19.8

HD

HR

8

15

M

36.0

18.0

CD

HR

9

9

M

36.0

18.0

CD

HR

10

8

F

36.0

18.0

CD

HR

11

5

F

36.0

18.0

CD

HR

12

4

F

36.0

18.0

HD

HR

  1. Abbreviations: M male, F female, HD high-dose chemotherapy, CD conventional-dose chemotherapy, SR standard-risk, and HR high-risk.